Abvc Biopharma ABVC
NASDAQ ABVC
$1.04 -0.01 (-0.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024)

Updated

Abvc Biopharma's Short-Term Debt issuances was $30,000 in FY2024.

Analysis

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024) Analysis & Trends

From FY2018 onward, Abvc Biopharma has reported Short-Term Debt issuances for 5 years.

  • Short-Term Debt issuances shows a five-year compound annual growth rate of -50.4% (FY2019 to FY2024).
  • The FY2024 figure marks the lowest annual Short-Term Debt issuances in data going back to FY2018.
  • Per Business Quant data, Short-Term Debt issuances in earlier years was $350,000 in FY2022 and $100,000 in FY2020 (-90.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 2.28 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Abvc Biopharma 27.36 Mn 26.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 30,000.00
Mar 31, 2021 10,651.00
Jun 30, 2020 -180,940.00
Mar 31, 2020 280,940.00
Dec 31, 2019 153,700.00
Dec 31, 2018 49,008.00
Sep 30, 2018 75,990.00
Jun 30, 2018 -256,550.00
Mar 31, 2018 312,824.00
API Access

Abvc Biopharma Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=ABVC&period=max&api_key=YOUR_API_KEY